Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program (Q46043878)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 April 2009

Language	Label	Description	Also known as
English	Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program	scientific article published on 19 April 2009

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

1 reference

based on heuristic

inferred from title

multivariate statistics

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

1

object named as

Henry Krum

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

author name string

Sean P Curtis

2

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

Amarjot Kaur

3

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

Hongwei Wang

4

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

Steven S Smugar

5

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

Matthew R Weir

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

Loren Laine

7

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

D Craig Brater

8

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

Christopher P Cannon

9

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

publication date

19 April 2009

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

European Journal of Heart Failure

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

11

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

542-550

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Celecoxib for the prevention of sporadic colorectal adenomas

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Blood pressure effects of COX-2 inhibitors.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Anti-inflammatory agents and renal function

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Cyclooxygenase-2 inhibition and renal physiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

The progression from hypertension to congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Vital epidemiologic clues in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Frequency of analgesic use and risk of hypertension among men

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Acetaminophen, aspirin, and chronic renal failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Lifetime Risk for Developing Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective Cyclooxygenase 2 inhibitors: A class effect?

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP054

21 January 2018

Identifiers

10.1093/EURJHF/HFP054

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19380329

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46043878&oldid=2089330571"